Results 61 to 70 of about 6,121,976 (420)
Measures of Accuracy for Continuous Glucose Monitoring and Blood Glucose Monitoring Devices
Journal of Diabetes Science and Technology, 2018 Currently, patients with diabetes may choose between two major types of system for glucose measurement: blood glucose monitoring (BGM) systems measuring glucose within capillary blood and continuous glucose monitoring (CGM) systems measuring glucose ...
G. Freckmann +4 more
semanticscholar +1 more source
FoxO1 signaling in B cell malignancies and its therapeutic targeting
FEBS Letters, EarlyView.FoxO1 has context‐specific tumor suppressor or oncogenic character in myeloid and B cell malignancies. This includes tumor‐promoting properties such as stemness maintenance and DNA damage tolerance in acute leukemias, or regulation of cell proliferation and survival, or migration in mature B cell malignancies.
Krystof Hlavac +3 more
wiley +1 more source
Is Estimation Of Blood Glucose By Glucometer More Reliable Than Laboratory Analysis? A Comparative Study Done At Rural Hospital Of Maharashtra [PDF]
Perspectives In Medical Research, 2022 Introduction: Diabetes is a major public health problem that is approaching epidemic proportions globally. Self-monitoring of blood glucose (SMBG) by the American Diabetes Association (ADA) is promoted in diabetic patients so that they achieve and ...
doaj +1 more source
Psychiatric Bulletin, 2007 The results reported by Dr Tarrant ( Psychiatric Bulletin , August 2006, 30 , 286–288) on blood glucose testing for adults prescribed atypical antipsychotics are far more impressive than we obtained when we audited prescribing on acute psychiatric wards in four health districts in the ...
Richard Hodgson, Nanda Dayalan
openaire +2 more sources
FEBS Letters, EarlyView.Metabolic dysfunction‐associated steatotic liver disease (MASLD) affects nearly one‐third of the global population and poses a significant risk of progression to cirrhosis or liver cancer. Here, we discuss the roles of hepatic dendritic cell subtypes in MASLD, highlighting their distinct contributions to disease initiation and progression, and their ...
Camilla Klaimi +3 more
wiley +1 more source
PERIOPERATIVE CONTROL OF BLOOD GLUCOSE
Medical Science and Discovery, 2015 This review mainly focuses on the management of type 2 diabetes in the preoperative setting with a special emphasis on intraoperative glycemic control. Some patients learn their diagnosis of diabetes just prior to the surgery. The prevalence of previously undiagnosed diabetes is reported to be 5,2-10% in literature. Treatment protocols must be tailored
KUŞKONMAZ, Serife, ARSLAN, Mustafa
openaire +4 more sources
Audit in practice : surveillance for hypoglycaemia in the neonatal paediatric intensive care unit [PDF]
, 1998 Hypoglycaemia in neonates is defined as a blood glucose ≤ 2.6 mmol/1. Certain categories of babies are at particularly high risk of developing hypoglycaemia in the first few days of life, and are routinely monitored in the Neonatal Paediatric Intensive ...
Grech, Victor E., Soler, Paul
core
Absorption spectroscopy of glucose based on a silicon photonics evanescent sensor [PDF]
, 2013 We present a silicon photonics evanescent sensor for glucose absorption spectroscopy. The important design aspects of this miniature sensor are discussed as well as the experimental challenges. We demonstrate detection of glucose down to 14 mmol/L, close
Baets, Roel +2 more
core +2 more sources
Skin-like biosensor system via electrochemical channels for noninvasive blood glucose monitoring
Science Advances, 2017 Electrochemical twin channels make glucose in vessels measurable by noninvasive ultrathin skin-like highly sensitive biosensors. Currently, noninvasive glucose monitoring is not widely appreciated because of its uncertain measurement accuracy, weak blood
Yihao Chen +8 more
semanticscholar +1 more source
Insights into PI3K/AKT signaling in B cell development and chronic lymphocytic leukemia
FEBS Letters, EarlyView.This Review explores how the phosphoinositide 3‐kinase and protein kinase B pathway shapes B cell development and drives chronic lymphocytic leukemia, a common blood cancer. It examines how signaling levels affect disease progression, addresses treatment challenges, and introduces novel experimental strategies to improve therapies and patient outcomes.
Maike Buchner
wiley +1 more source